AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

Identification of Auro-Efavirenz-Emtricitabine-Tenofovir

No description

Google image searchProduct monograph

Active ingredients

efavirenz, 600 MG

emtricitabine, 200 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02478404

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: AURO PHARMA INC

Date: 18-MAR-2020

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR06 — EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ (ATC/DDD)

Reference brand drug: Atripla

External Links for Auro-Efavirenz-Emtricitabine-Tenofovir

Search on Google

• Auro-Efavirenz-Emtricitabine-Tenofovir side effects
• Auro-Efavirenz-Emtricitabine-Tenofovir dosage
• efavirenz side effects
• efavirenz dosage
• emtricitabine side effects
• emtricitabine dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage

Auro Pharma Inc

Go to Auro Pharma website to see drug product details. Sometimes you can find auro-efavirenz-emtricitabine-tenofovir photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.